Taras I. Griadil

Uzhgorod, Ukraine

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

The clinical and pathogenetic manifestations of gastroesophageal reflux disease and obesity and approaches to their diagnosis, treatment, and prevention: current state of the problem (literature review).

The clinical and pathogenetic manifestations of gastroesophageal reflux disease and obesity and approaches to their diagnosis, treatment, and prevention: current state of the problem (literature review).

Journal: Wiadomosci lekarskie (Warsaw, Poland : 1960)

Published: May 14, 2025

Obesity and heart failure with preserved ejection fraction.

Obesity and heart failure with preserved ejection fraction.

Journal: Wiadomosci lekarskie (Warsaw, Poland : 1960)

Published: May 01, 2024

PREDICTING PROGRESSION TYPE 2 DIABETES MELLITUS: A 3-YEAR FOLLOW-UP STUDY EXAMINING RISK FACTORS FOR TYPE 2 DIABETES IN PATIENTS WITH PREDIABETES.

PREDICTING PROGRESSION TYPE 2 DIABETES MELLITUS: A 3-YEAR FOLLOW-UP STUDY EXAMINING RISK FACTORS FOR TYPE 2 DIABETES IN PATIENTS WITH PREDIABETES.

Journal: Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego

Published: August 17, 2023

THE INFLUENCE OF SPELEOTHERAPY ON BRONCHI PASSAGE IN CHILDREN WITH BRONCHIAL ASTHMA USING A PHARMACO-FUNCTIONAL TEST WITH SALBUTAMOL.

THE INFLUENCE OF SPELEOTHERAPY ON BRONCHI PASSAGE IN CHILDREN WITH BRONCHIAL ASTHMA USING A PHARMACO-FUNCTIONAL TEST WITH SALBUTAMOL.

Journal: Wiadomosci lekarskie (Warsaw, Poland : 1960)

Published: April 14, 2023

EFFECT OF INTERMITTENT FASTING ON CARBOHYDRATE, LIPID AND ULTRASONOGRAPHIC PARAMETERS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE AND PREDIABETES.

EFFECT OF INTERMITTENT FASTING ON CARBOHYDRATE, LIPID AND ULTRASONOGRAPHIC PARAMETERS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE AND PREDIABETES.

Journal: Wiadomosci lekarskie (Warsaw, Poland : 1960)

Published: April 14, 2023

THE CLINICAL PRESENTATION OF SUBCLINICAL HYPOTHYROIDISM IN PATIENTS WITH TYPE 2 DIABETES MELLITUS ASSOCIATED WITH OBESITY, ITS IMPACT ON CARDIOVASCULAR RISK, AND WAYS OF ITS CORRECTION.

THE CLINICAL PRESENTATION OF SUBCLINICAL HYPOTHYROIDISM IN PATIENTS WITH TYPE 2 DIABETES MELLITUS ASSOCIATED WITH OBESITY, ITS IMPACT ON CARDIOVASCULAR RISK, AND WAYS OF ITS CORRECTION.

Journal: Wiadomosci lekarskie (Warsaw, Poland : 1960)

Published: December 19, 2021

ASSESSMENT OF CARDIOVASCULAR RISK IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND ASSOCIATED OBESITY AND WAYS OF ITS CORRECTION.

ASSESSMENT OF CARDIOVASCULAR RISK IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND ASSOCIATED OBESITY AND WAYS OF ITS CORRECTION.

Journal: Wiadomosci lekarskie (Warsaw, Poland : 1960)

Published: June 22, 2021

Comparison of the effect of dapagliflozin on contrast to standard therapy of the patients with type 2 diabetes mellitus and concomitant obesity, their effect on laboratory and anthropometric parameters.

Comparison of the effect of dapagliflozin on contrast to standard therapy of the patients with type 2 diabetes mellitus and concomitant obesity, their effect on laboratory and anthropometric parameters.

Journal: Wiadomosci lekarskie (Warsaw, Poland : 1960)

Published: April 15, 2020

Peculiarities of diagnostics of depressions and clinical manifestations in patients with obesity and concomitant type 2 diabetes mellitus.

Peculiarities of diagnostics of depressions and clinical manifestations in patients with obesity and concomitant type 2 diabetes mellitus.

Journal: Wiadomosci lekarskie (Warsaw, Poland : 1960)

Published: May 06, 2019

Showing 1-9 of 9

Last Updated: 09/26/2026